Our Active Trades Performance in September
-
Cyclopharm (ASX:CYC)
CYCMarch 31, 2023Up to $2.20$2.79$2.25$3.0070.1% -
Weebit Nano (ASX: WBT)
WBTMay 17, 2022Up to $5.00$3.15$3.50$9.5641.9%
-
Cyclopharm (ASX:CYC)
CYCMarch 31, 2023$2.7970.1% -
Weebit Nano (ASX: WBT)
WBTMay 17, 2022$3.1541.9%
Stocks Down Under’s Team Of Experts Has Put Together
Top 3 ASX Stocks To Invest In Right Now!
Get our Industry Experts’ reports and recommendations, along with BUY and SELL Alerts for ASX-listed Stocks with Stocks Down Under’s Concierge. Sign up to see our trades.
Our Service
A curated set of BUY and SELL alerts on stocks that we know intimately well.
We will only send out alerts on very high conviction stocks.
Our alerts are sent through email and SMS, depending on your preference.
We aim for target performances of around 20% to 40% per trade.
What the Concierge Report Offers:
Comprehensive and concise updates on current and past trade
We contextualise day to day market movements with our view of the overall market valuation so you can focus on the long-term investment opportunity. Explore index, commodity and currency changes See the current price to fair value of each market we cover along with the valuation from a year ago.
Analysis of Pricing, Target Price, catalysts and Key risks at hand
Our report offers a comprehensive analysis of pricing, target price, catalysts, and key risks associated with each recommended stock. We evaluate the stock's current pricing relative to its historical performance and industry peers, providing insights into its valuation.
Detailed Research on proposed investments
Our stock report service provides detailed research on proposed investments, offering in-depth analysis of companies and their financial performance. Our reports also include qualitative and quantitative assessments, providing investors with a comprehensive understanding of the potential risks and rewards associated with each investment.
Constant and Consistent Updates for Recommended Stocks
We provide constant and consistent updates for recommended stocks, ensuring that investors stay informed about any significant developments or changes. We deliver timely updates on company news, financial performance, and market trends that may impact the recommended stocks.
Our Track Record For 2023 So Far
Leo Lithium
(ASX: LLL)
8 May 2023
$0.565
31 May 2023
$0.885
Returns of 56.5% in less than 30 Days!
InfoMedia
(ASX: IFM)
8 Dec. 2022
Upto $1.25
21 Mar. 2023
$1.455
Returns of 34.1% in less than 5 Months!
Flight Centre
(ASX: FLT)
6 Oct. 2022
Upto $15.30
23 Feb. 2023
$18.48
Returns of 24.1% in less than 6 months!
We’re Trusted and Backed by
3-month Free Trial
No Credit Card Details Necessary.
Full access to all the Concierge services.
The Team Behind Concierge
Stuart Roberts
Co-Founder
Stuart Roberts is the co-founder of Stocks Down Under. Previously, Stuart covered the healthcare and biotechnology sectors at NDF Research and at stockbroking firms Southern Cross Equities, Bell Potter and Baillieu Holst from 2002 to 2015, where he developed a reputation for detailed analysis on previously uncovered Life Science companies. In 2018, he co-founded Pitt Street Research
Marc Kennis
Co-Founder
Marc is the co-founder of Stocks Down Under and has 20+ years experience analyzing companies in a range of sectors, including Food & Beverage, Industrials, Technology, Medical Equipment, Telecom and Media. Prior to moving to Australia in 2014, he worked for a number of brokers and banks in The Netherlands, including ING and Rabobank. In 2018, Marc co-founded Pitt Street Research,
Peter Kilby
Head of Customer Service
Pete is Stocks Down Under's head of customer service. He is an avid investor with a knack for deep-dive company research. Pete likes the more established companies on ASX, but doesn't shy away from the occasional risky play. At Stocks Down Under he gets to do the two things he loves most, investing and talking to like-minded people.
STUART ROBERTSStuart Roberts is the co-founder of Stocks Down Under. Previously, Stuart covered the healthcare and biotechnology sectors at NDF Research and at stockbroking firms Southern Cross Equities, Bell Potter and Baillieu Holst from 2002 to 2015, where he developed a reputation for detailed analysis on previously uncovered Life Science companies. In 2018, he co-founded Pitt Street Research together with Marc.
MARC KENNISMarc is the co-founder of Stocks Down Under and has 20+ years experience analyzing companies in a range of sectors, including Food & Beverage, Industrials, Technology, Medical Equipment, Telecom and Media. Prior to moving to Australia in 2014, he worked for a number of brokers and banks in The Netherlands, including ING and Rabobank. In 2018, Marc co-founded Pitt Street Research, Australia's preeminent issuer-sponsored equities research firm.
PETER KILBYPete is Stocks Down Under's head of customer service. He is an avid investor with a knack for deep-dive company research. Pete likes the more established companies on ASX, but doesn't shy away from the occasional risky play. At Stocks Down Under he gets to do the two things he loves most, investing and talking to like-minded people.
Get in touch
contact@stocksdownunder.com
Follow us on
